Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine (SP) plus amodiaquine (AQ), given each month during the transmission season, is recommended for children living in areas of the Sahel where malaria transmission is highly seasonal. The recommendation for SMC is currently limited to children under five years of age, but, in many areas of seasonal transmission, the burden in older children may justify extending this age limit. This study was done to determine the effectiveness of SMC in Senegalese children up to ten years of age. METHODS AND FINDINGS: SMC was introduced into three districts over three years in central Senegal using a stepped-wedge cluster-randomised design. A census of the population was undertaken and a surveillance system was established to record all deaths and to record all cases of malaria seen at health facilities. A pharmacovigilance system was put in place to detect adverse drug reactions. Fifty-four health posts were randomised. Nine started implementation of SMC in 2008, 18 in 2009, and a further 18 in 2010, with 9 remaining as controls. In the first year of implementation, SMC was delivered to children aged 3-59 months; the age range was then extended for the latter two years of the study to include children up to 10 years of age. Cluster sample surveys at the end of each transmission season were done to measure coverage of SMC and the prevalence of parasitaemia and anaemia, to monitor molecular markers of drug resistance, and to measure insecticide-treated net (ITN) use. Entomological monitoring and assessment of costs of delivery in each health post and of community attitudes to SMC were also undertaken. About 780,000 treatments were administered over three years. Coverage exceeded 80% each month. Mortality, the primary endpoint, was similar in SMC and control areas (4.6 and 4.5 per 1000 respectively in children under 5 years and 1.3 and 1.2 per 1000 in children 5-9 years of age; the overall mortality rate ratio [SMC: no SMC] was 0.90, 95% CI 0.68-1.2, p = 0.496). A reduction of 60% (95% CI 54%-64%, p < 0.001) in the incidence of malaria cases confirmed by a rapid diagnostic test (RDT) and a reduction of 69% (95% CI 65%-72%, p < 0.001) in the number of treatments for malaria (confirmed and unconfirmed) was observed in children. In areas where SMC was implemented, incidence of confirmed malaria in adults and in children too old to receive SMC was reduced by 26% (95% CI 18%-33%, p < 0.001) and the total number of treatments for malaria (confirmed and unconfirmed) in these older age groups was reduced by 29% (95% CI 21%-35%, p < 0.001). One hundred and twenty-three children were admitted to hospital with a diagnosis of severe malaria, with 64 in control areas and 59 in SMC areas, showing a reduction in the incidence rate of severe disease of 45% (95% CI 5%-68%, p = 0.031). Estimates of the reduction in the prevalence of parasitaemia at the end of the transmission season in SMC areas were 68% (95% CI 35%-85%) p = 0.002 in 2008, 84% (95% CI 58%-94%, p < 0.001) in 2009, and 30% (95% CI -130%-79%, p = 0.56) in 2010. SMC was well tolerated with no serious adverse reactions attributable to SMC drugs. Vomiting was the most commonly reported mild adverse event but was reported in less than 1% of treatments. The average cost of delivery was US$0.50 per child per month, but varied widely depending on the size of the health post. Limitations included the low rate of mortality, which limited our ability to detect an effect on this endpoint. CONCLUSIONS: SMC substantially reduced the incidence of outpatient cases of malaria and of severe malaria in children, but no difference in all-cause mortality was observed. Introduction of SMC was associated with an overall reduction in malaria incidence in untreated age groups. In many areas of Africa with seasonal malaria, there is a substantial burden in older children that could be prevented by SMC. SMC in older children is well tolerated and effective and can contribute to reducing malaria transmission. TRIAL REGISTRATION: ClinicalTrials.gov NCT00712374.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Health facilities, strategically chosen as clusters in numerous studies, underscore the emphasis on healthcare delivery and interventions within controlled environments.”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The everyday use of hospitals and clinics as clusters is rooted in their pivotal role in healthcare delivery, enabling the implementation and evaluation of interventions to enhance patient outcomes (26, 27, 30–34, 36–47, 49, 50, 52–71, 73–75, 77–81, 83–89, 91–96, 98–102, 104, 105, 107, 109).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies that integrated health facility-based interventions with community outreach often used mixed-setting clusters (33–36, 38, 48, 54, 61, 67, 72, 76, 78, 80, 92, 99, 103, 106–108).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
The cited source says what the claim attributes to it.
In the citing paper
“Many of the interventions involved distributing and administering pharmaceutical treatments to prevent or manage diseases (28, 34, 36, 38–40, 42, 61, 90, 91, 93, 96, 98).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
The cited source says what the claim attributes to it.
In the citing paper
“Studies such as those by Calum Davey (35) and Badara Cisse (34) illustrate the value of accounting for temporal trends to reduce bias, aligning with guidance on SWD's analytical strengths (117).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The stepped wedge trial design: a systematic review
Brown, C. A., & Lilford, R. J. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-54 · Cited by 907
Cissé, B., Sokhna, C., Boulanger, D., Milet, J., Bâ, E. H., Richardson, K., Hallett, R., Sutherland, C., Simondon, K., Simondon, F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68264-0 · Cited by 209 · cited 1×
“Stepped-Wedge Design SMC (then known as intermittent preventive treatment in children [IPTc]) had been shown prior to the planning of this study to be highly effective in clinical trials [10,11], but it was questioned whether the intervention could be delivered on a large scale at reasonable cost, whether it would be…”
MethodCairns, M., Roca-Feltrer, A., Garske, T., Wilson, A. L., Diallo, D., Milligan, P. J., Ghani, A. C., & Greenwood, B. M. (2012) · Nature Communications · doi:10.1038/ncomms1879 · Cited by 186 · cited 1×
“1 cases per child per year, areas where SMC is likely to be most cost effective [2,3].”
BackgroundOkiro, E. A., Al-Taiar, A., Reyburn, H., Idro, R., Berkley, J. A., & Snow, R. W. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-4 · Cited by 153 · cited 1×
“In some parts of the areas suitable for SMC, the proportional burden of malaria in older children is increasing [7], reflecting slower acquisition of natural immunity; in these areas, Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten”
BackgroundHemming, K., & Girling, A. (2014) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1401400208 · Cited by 127
Sokhna, C., Cissé, B., Bâ, E. H., Milligan, P., Hallett, R., Sutherland, C., Gaye, O., Boulanger, D., Simondon, K., Simondon, F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001471 · Cited by 99
NDiaye, J. L., Cissé, B., Ba, E. H., Gomis, J. F., Ndour, C. T., Molez, J. F., Fall, F. B., Sokhna, C., Faye, B., Kouevijdin, E., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162563 · Cited by 60
Self-citationNew Malaria-Control Policies and Child Mortality in Senegal: Reaching Millennium Development Goal 4
Trape, J.-F., Sauvage, C., Ndiaye, O., Douillot, L., Marra, A., Diallo, A., Cisse, B., Greenwood, B., Milligan, P., Sokhna, C., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir805 · Cited by 36
Noor, A. M., Kibuchi, E., Mitto, B., Coulibaly, D. M., Doumbo, O. K., & Snow, R. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136919 · Cited by 36
Lô, A. C., Faye, B. T., Bâ, E. H., et al. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-137 · Cited by 27 · cited 3×
“falciparum infection at the end of the transmission season were more likely to carry the pfmdr1 86Y mutation associated with AQ resistance if they came from areas where SMC had been implemented [14], but the effect of this on the spread of resistance may be mitigated to some extent by the much lower prevalence of infe…”
BackgroundInfluential
Cited by
White, N. J. (2018) · Malaria Journal · doi:10.1186/s12936-018-2509-9 · Cited by 563
Ashley, E. A., Pyae Phyo, A., & Woodrow, C. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30324-6 · Cited by 553
Selecting and Improving Quasi-Experimental Designs in Effectiveness and Implementation Research
Handley, M. A., Lyles, C. R., McCulloch, C., & Cattamanchi, A. (2018) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-040617-014128 · Cited by 428
“…to implementation processes that could impact interpretation of findings such as academic vs community affiliation, urban vs rural (bed size) Cissé et al 2016 Randomized stepped wedge cluster trial Seasonal malaria prophylaxis for children up to age 10 in central Senegal given to households…”
BackgroundAntimalarial drug resistance in Africa: the calm before the storm?
Conrad, M. D., & Rosenthal, P. J. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30261-0 · Cited by 255
Baba, E., Hamade, P., Kivumbi, H., Marasciulo, M., Maxwell, K., Moroso, D., Roca-Feltrer, A., Sanogo, A., Stenstrom Johansson, J., Tibenderana, J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32227-3 · Cited by 244
Metadata
- Authors
- Cissé, B., Ba, E. H., Sokhna, C., NDiaye, J. L., Gomis, J. F., Dial, Y., Pitt, C., NDiaye, M., Cairns, M., Faye, E., NDiaye, M., Lo, A., Tine, R., Faye, S., Faye, B., Sy, O., Konate, L., Kouevijdin, E., Flach, C., Faye, O., Trape, J.-F., Sutherland, C., Fall, F. B., Thior, P. M., Faye, O. K., Greenwood, B., Gaye, O., & Milligan, P.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- Institut de Recherche pour le Développement (SN)
- Cheikh Anta Diop University (SN)
- Corresponding author
- Milligan, Paul
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-11-22
- Volume
- 13
- Issue
- 11
- Pages
- e1002175
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5119693
- OpenAlex
- W2549904414
- Semantic Scholar
- e6a098bdd1abc4b8af46ccccb9f99306619a22fa
- Cited by
- 191
- References
- 10
- Citations by year
- 2026: 23 · 2025: 21 · 2024: 22 · 2023: 15 · 2022: 24 · 2021: 25 · 2020: 23 · 2019: 10 · 2018: 17 · 2017: 9 · 2016: 2
- FWCI
- 12.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Funders
- Bill and Melinda Gates Foundation (40099)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- seasonal malaria chemoprevention, sulfadoxine-pyrimethamine, amodiaquine, malaria mortality, parasitemia, anemia, drug resistance, insecticide-treated nets, adverse drug reactions, community attitudes, Senegal
- MeSH terms
- Amodiaquine, Antimalarials, Child, Child, Preschool, Drug Combinations, Humans, Infant, Malaria, Pyrimethamine, Seasons, Senegal, Sulfadoxine, Chemoprevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial. https://app.cochat.ai/papers/10.1371/journal.pmed.1002175
- The paper
- Cissé, B., Ba, E. H., Sokhna, C., NDiaye, J. L., Gomis, J. F., Dial, Y., Pitt, C., NDiaye, M., Cairns, M., Faye, E., NDiaye, M., Lo, A., Tine, R., Faye, S., Faye, B., Sy, O., Konate, L., Kouevijdin, E., Flach, C., . . . Milligan, P. (2016). Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial. PLoS Medicine. https://doi.org/10.1371/journal.pmed.1002175
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.